CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 22(Granted Patents)

Location History:

Mississauga, CA (2015 - 2016)
Etobicoke, CA (2008 - 2019)

Company Filing History:

6 out of 18

Alphora Research Inc.

Years Active: 2008-2019

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10301274 - Crystalline derivatives of (S)-1-((2R,3R,4S,5S)-5-allyl-3-methoxy-4-(tosylmethyl)tetrahydrofuran-2-YL)-3-aminopropan-2-ol (2019-05-28),

2. 9695187 - Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein (2017-07-04),

3. 9650397 - 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof (2017-05-16),

4. 9416140 - Process for preparation of 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof (2016-08-16),

5. 9278979 - Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein (2016-03-08),

6. 9174956 - Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof (2015-11-03),

7. 7321047 - Separation of tetrahydrocannabinols (2008-01-22),

Title: The Innovative Contributions of Ricardo Orprecio

Introduction

Ricardo Orprecio is a notable inventor based in Etobicoke, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can lead to new treatments. With a total of 7 patents to his name, Orprecio's work is recognized for its potential impact on medical science.

Latest Patents

Orprecio's latest patents include groundbreaking work on crystalline derivatives of a specific compound. This compound, identified as (S)-1-((2R,3R,4S,5S)-5-allyl-3-methoxy-4-(tosylmethyl)tetrahydrofuran-2-YL)-3-aminopropan-2-ol, involves the disclosure of salts that can be useful for the preparation of halichondrin analogs, such as eribulin. Additionally, he has developed a synthetic process for preparing macrocyclic C1-keto analogs of halichondrin B, which also includes the preparation of pharmaceutically acceptable salts.

Career Highlights

Throughout his career, Orprecio has worked with prominent companies in the pharmaceutical industry. Notable among these are Alphora Research Inc. and Sandoz AG. His experience in these organizations has allowed him to collaborate on various innovative projects that push the boundaries of current medical treatments.

Collaborations

Orprecio has collaborated with several professionals in his field, including Boris Gorin and Fabio E S Souza. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Ricardo Orprecio's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and compounds.

This text is generated by artificial intelligence and may not be accurate.